4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-17-004754
President and CEO bought 22,223 shares at $4.50 ($100,004)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2017-02-17 | Purchase | +22,223 | $4.50 | $100,004 | 64,408 | D |
| Open-market purchases · 22,223 sh · avg $4.50 · $100,004 | |||||||
Loading xslF345X03/doc4.xml…